<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02784990</url>
  </required_header>
  <id_info>
    <org_study_id>FACY PHRCI 2015</org_study_id>
    <nct_id>NCT02784990</nct_id>
  </id_info>
  <brief_title>Study of Pancreatic Enzymes in the Drains as Early Biomarkers of Post-operative Pancreatic Fistula and Its Clinical Repercussions</brief_title>
  <acronym>LIPA-DRAIN</acronym>
  <official_title>Study of Pancreatic Enzymes in the Drains as Early Biomarkers of Post-operative Pancreatic Fistula and Its Clinical Repercussions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      Surgery is the principal treatment for benign and malignant pancreatic tumours. This surgery
      can be accompanied by complications among which the main one is pancreatic fistula, which
      leads to the flow of pancreatic juices into the abdominal cavity. Depending on its severity,
      a fistula can be managed medically, with the implantation of a la pose d'un percutaneous
      drain, endoscopic treatment, or revisit surgery. It has been shown that early management of
      the fistula prevents it from evolving towards major complications such as haemorrhage or
      serious intra-abdominal infections.

      To date, the early diagnosis of pancreatic fistula is based on high levels of one pancreatic
      enzyme, amylase, in the drains. However in certain clinical situations, patients present
      post-operative fistulas with no elevation of amylase. And, on the contrary, increased amylase
      with no clinical consequences.

      It is therefore necessary to identify another early early marker of pancreatic fistula that
      corresponds better to clinical signs.

      In a preliminary study conducted in 65 patients, the investigators recently found that
      another pancreatic enzyme (lipase) could be a more pertinent marker of pancreatic fistula,
      but this requires confirmation in a greater number of patients.

      The objective is to evaluate the diagnostic performance of lipase in the drains for the early
      detection of pancreatic fistula with clinical repercussions in the 30 days following the
      surgery.

      The study consists in collecting at 4 different time points (D1, D3, D4 and D6) a tube of
      blood and a tube of drain liquid.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dosage of lipase in the drains</measure>
    <time_frame>3 days after surgical resection</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">670</enrollment>
  <condition>Pancreatic Fistula</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Lipase, amylase and CRP (C-reactive protein) dosages</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 18

          -  Patients undergoing scheduled pancreatic resection with or without anastomosis
             (cephalic duodenopancreatectomy, median pancreatectomy, left pancreatectomy,
             enucleation)

          -  Patients able to understand instructions/information

          -  Patients who have provided written informed consent

          -  Patients with Health Insurance cover

        Exclusion Criteria:

          -  Patients with scheduled total pancreatectomy

          -  Adults under wardship

          -  Pregnant or breast-feeding women

          -  Total pancreatectomy

          -  Pancreatectomy not feasible
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Jean Minjoz</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brice PAQUETTE</last_name>
      <phone>03.81.66.82.43</phone>
      <phone_ext>+33</phone_ext>
      <email>bpaquette@chu-besancon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU William MOREY</name>
      <address>
        <city>Chalon-sur-Saône</city>
        <zip>71321</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claire CHALUMEAU</last_name>
      <phone>03.85.44.66.88</phone>
      <phone_ext>+33</phone_ext>
      <email>claire.chalumeau@ch-chalon71.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier FACY</last_name>
      <phone>03.80.29.37.47</phone>
      <phone_ext>+33</phone_ext>
      <email>olivier.facy@chu-dijon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Pablo ORTEGA DEBALLON</last_name>
      <phone>03.80.29.37.47</phone>
      <phone_ext>+33</phone_ext>
      <email>pablo.ortega-deballon@chu-dijon.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CHU de REIMS - Hôpital Robert Debré</name>
      <address>
        <city>Reims</city>
        <zip>51100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Reza KIANMANESH</last_name>
      <phone>03.26.78.70.95</phone>
      <phone_ext>+33</phone_ext>
      <email>rkianmanesh@chu-reims.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe BACHELLIER</last_name>
      <phone>03.88.12.72.58</phone>
      <phone_ext>+33</phone_ext>
      <email>Philippe.bachellier@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de NANCY</name>
      <address>
        <city>Vandoeuvre Les Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laurent BRESLER</last_name>
      <phone>03.83.15.42.07</phone>
      <phone_ext>+33</phone_ext>
      <email>l.bresler@chu-nancy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2016</study_first_submitted>
  <study_first_submitted_qc>May 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2016</study_first_posted>
  <last_update_submitted>May 26, 2016</last_update_submitted>
  <last_update_submitted_qc>May 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Pancreatic Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

